Global Pediatric Orphan Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Pediatric Orphan Drugs market size was valued at USD 52980 million in 2022 and is forecast to a readjusted size of USD 103570 million by 2029 with a CAGR of 10.0% during review period.

Pediatric orphan drugs are medications that are specifically developed and approved for the treatment of rare diseases or conditions in children. These drugs are designed to address medical needs in pediatric populations who have limited treatment options due to the rarity of their conditions. Pediatric orphan drugs are vital in addressing the unique medical needs of children with rare diseases and improving their health outcomes and quality of life.

According to our “ Pharma & Healthcare Research Center” statistics, the global sales of Orphan Drugs reached $139170 million in 2022. The North America region was the world largest Orphan Drugs market, accounting for 40% of Orphan Drugs sales in 2022,  followed by Asia-Pacific. The global market for pediatric orphan drugs has been growing steadily in recent years due to increasing awareness of rare pediatric diseases, advancements in medical research and technology, and improved regulatory support for pediatric drug development.

The Global Info Research report includes an overview of the development of the Pediatric Orphan Drugs industry chain, the market status of Hospital Pharmacies (Oncology Drugs, Gastrointestinal Drugs), Retail pharmacies (Oncology Drugs, Gastrointestinal Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pediatric Orphan Drugs.

Regionally, the report analyzes the Pediatric Orphan Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pediatric Orphan Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Pediatric Orphan Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pediatric Orphan Drugs industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncology Drugs, Gastrointestinal Drugs).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pediatric Orphan Drugs market.

Regional Analysis: The report involves examining the Pediatric Orphan Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pediatric Orphan Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Pediatric Orphan Drugs:
Company Analysis: Report covers individual Pediatric Orphan Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pediatric Orphan Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail pharmacies).

Technology Analysis: Report covers specific technologies relevant to Pediatric Orphan Drugs. It assesses the current state, advancements, and potential future developments in Pediatric Orphan Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pediatric Orphan Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Pediatric Orphan Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Oncology Drugs
    Gastrointestinal Drugs
    Neurology Drugs
    Cardio-vascular Drugs
    Others

Market segment by Application
    Hospital Pharmacies
    Retail pharmacies
    Others

Market segment by players, this report covers
    Recordati SpA
    Novartis
    Celgene
    Abbvie
    Orpharma
    Amgen
    Amryt Pharma Plc.
    Johnson & Johnson
    GSK
    Bristol-Myers Squibb Company
    Roche Holding
    Pfizer
    Sanofi
    Takeda

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pediatric Orphan Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pediatric Orphan Drugs, with revenue, gross margin and global market share of Pediatric Orphan Drugs from 2018 to 2023.
Chapter 3, the Pediatric Orphan Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pediatric Orphan Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pediatric Orphan Drugs.
Chapter 13, to describe Pediatric Orphan Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Pediatric Orphan Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Pediatric Orphan Drugs by Type
        1.3.1 Overview: Global Pediatric Orphan Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Pediatric Orphan Drugs Consumption Value Market Share by Type in 2022
        1.3.3 Oncology Drugs
        1.3.4 Gastrointestinal Drugs
        1.3.5 Neurology Drugs
        1.3.6 Cardio-vascular Drugs
        1.3.7 Others
    1.4 Global Pediatric Orphan Drugs Market by Application
        1.4.1 Overview: Global Pediatric Orphan Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Retail pharmacies
        1.4.4 Others
    1.5 Global Pediatric Orphan Drugs Market Size & Forecast
    1.6 Global Pediatric Orphan Drugs Market Size and Forecast by Region
        1.6.1 Global Pediatric Orphan Drugs Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Pediatric Orphan Drugs Market Size by Region, (2018-2029)
        1.6.3 North America Pediatric Orphan Drugs Market Size and Prospect (2018-2029)
        1.6.4 Europe Pediatric Orphan Drugs Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Pediatric Orphan Drugs Market Size and Prospect (2018-2029)
        1.6.6 South America Pediatric Orphan Drugs Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Pediatric Orphan Drugs Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Recordati SpA
        2.1.1 Recordati SpA Details
        2.1.2 Recordati SpA Major Business
        2.1.3 Recordati SpA Pediatric Orphan Drugs Product and Solutions
        2.1.4 Recordati SpA Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Recordati SpA Recent Developments and Future Plans
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Pediatric Orphan Drugs Product and Solutions
        2.2.4 Novartis Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Novartis Recent Developments and Future Plans
    2.3 Celgene
        2.3.1 Celgene Details
        2.3.2 Celgene Major Business
        2.3.3 Celgene Pediatric Orphan Drugs Product and Solutions
        2.3.4 Celgene Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Celgene Recent Developments and Future Plans
    2.4 Abbvie
        2.4.1 Abbvie Details
        2.4.2 Abbvie Major Business
        2.4.3 Abbvie Pediatric Orphan Drugs Product and Solutions
        2.4.4 Abbvie Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Abbvie Recent Developments and Future Plans
    2.5 Orpharma
        2.5.1 Orpharma Details
        2.5.2 Orpharma Major Business
        2.5.3 Orpharma Pediatric Orphan Drugs Product and Solutions
        2.5.4 Orpharma Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Orpharma Recent Developments and Future Plans
    2.6 Amgen
        2.6.1 Amgen Details
        2.6.2 Amgen Major Business
        2.6.3 Amgen Pediatric Orphan Drugs Product and Solutions
        2.6.4 Amgen Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Amgen Recent Developments and Future Plans
    2.7 Amryt Pharma Plc.
        2.7.1 Amryt Pharma Plc. Details
        2.7.2 Amryt Pharma Plc. Major Business
        2.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Product and Solutions
        2.7.4 Amryt Pharma Plc. Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Amryt Pharma Plc. Recent Developments and Future Plans
    2.8 Johnson & Johnson
        2.8.1 Johnson & Johnson Details
        2.8.2 Johnson & Johnson Major Business
        2.8.3 Johnson & Johnson Pediatric Orphan Drugs Product and Solutions
        2.8.4 Johnson & Johnson Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Johnson & Johnson Recent Developments and Future Plans
    2.9 GSK
        2.9.1 GSK Details
        2.9.2 GSK Major Business
        2.9.3 GSK Pediatric Orphan Drugs Product and Solutions
        2.9.4 GSK Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 GSK Recent Developments and Future Plans
    2.10 Bristol-Myers Squibb Company
        2.10.1 Bristol-Myers Squibb Company Details
        2.10.2 Bristol-Myers Squibb Company Major Business
        2.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Product and Solutions
        2.10.4 Bristol-Myers Squibb Company Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
    2.11 Roche Holding
        2.11.1 Roche Holding Details
        2.11.2 Roche Holding Major Business
        2.11.3 Roche Holding Pediatric Orphan Drugs Product and Solutions
        2.11.4 Roche Holding Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Roche Holding Recent Developments and Future Plans
    2.12 Pfizer
        2.12.1 Pfizer Details
        2.12.2 Pfizer Major Business
        2.12.3 Pfizer Pediatric Orphan Drugs Product and Solutions
        2.12.4 Pfizer Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Pfizer Recent Developments and Future Plans
    2.13 Sanofi
        2.13.1 Sanofi Details
        2.13.2 Sanofi Major Business
        2.13.3 Sanofi Pediatric Orphan Drugs Product and Solutions
        2.13.4 Sanofi Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Sanofi Recent Developments and Future Plans
    2.14 Takeda
        2.14.1 Takeda Details
        2.14.2 Takeda Major Business
        2.14.3 Takeda Pediatric Orphan Drugs Product and Solutions
        2.14.4 Takeda Pediatric Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Takeda Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Pediatric Orphan Drugs Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Pediatric Orphan Drugs by Company Revenue
        3.2.2 Top 3 Pediatric Orphan Drugs Players Market Share in 2022
        3.2.3 Top 6 Pediatric Orphan Drugs Players Market Share in 2022
    3.3 Pediatric Orphan Drugs Market: Overall Company Footprint Analysis
        3.3.1 Pediatric Orphan Drugs Market: Region Footprint
        3.3.2 Pediatric Orphan Drugs Market: Company Product Type Footprint
        3.3.3 Pediatric Orphan Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Pediatric Orphan Drugs Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Pediatric Orphan Drugs Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Pediatric Orphan Drugs Consumption Value Market Share by Application (2018-2023)
    5.2 Global Pediatric Orphan Drugs Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Pediatric Orphan Drugs Consumption Value by Type (2018-2029)
    6.2 North America Pediatric Orphan Drugs Consumption Value by Application (2018-2029)
    6.3 North America Pediatric Orphan Drugs Market Size by Country
        6.3.1 North America Pediatric Orphan Drugs Consumption Value by Country (2018-2029)
        6.3.2 United States Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        6.3.3 Canada Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        6.3.4 Mexico Pediatric Orphan Drugs Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Pediatric Orphan Drugs Consumption Value by Type (2018-2029)
    7.2 Europe Pediatric Orphan Drugs Consumption Value by Application (2018-2029)
    7.3 Europe Pediatric Orphan Drugs Market Size by Country
        7.3.1 Europe Pediatric Orphan Drugs Consumption Value by Country (2018-2029)
        7.3.2 Germany Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        7.3.3 France Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        7.3.5 Russia Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        7.3.6 Italy Pediatric Orphan Drugs Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Pediatric Orphan Drugs Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Pediatric Orphan Drugs Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Pediatric Orphan Drugs Market Size by Region
        8.3.1 Asia-Pacific Pediatric Orphan Drugs Consumption Value by Region (2018-2029)
        8.3.2 China Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        8.3.3 Japan Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        8.3.4 South Korea Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        8.3.5 India Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        8.3.7 Australia Pediatric Orphan Drugs Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Pediatric Orphan Drugs Consumption Value by Type (2018-2029)
    9.2 South America Pediatric Orphan Drugs Consumption Value by Application (2018-2029)
    9.3 South America Pediatric Orphan Drugs Market Size by Country
        9.3.1 South America Pediatric Orphan Drugs Consumption Value by Country (2018-2029)
        9.3.2 Brazil Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        9.3.3 Argentina Pediatric Orphan Drugs Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Pediatric Orphan Drugs Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Pediatric Orphan Drugs Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Pediatric Orphan Drugs Market Size by Country
        10.3.1 Middle East & Africa Pediatric Orphan Drugs Consumption Value by Country (2018-2029)
        10.3.2 Turkey Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Pediatric Orphan Drugs Market Size and Forecast (2018-2029)
        10.3.4 UAE Pediatric Orphan Drugs Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Pediatric Orphan Drugs Market Drivers
    11.2 Pediatric Orphan Drugs Market Restraints
    11.3 Pediatric Orphan Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Pediatric Orphan Drugs Industry Chain
    12.2 Pediatric Orphan Drugs Upstream Analysis
    12.3 Pediatric Orphan Drugs Midstream Analysis
    12.4 Pediatric Orphan Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Pediatric Orphan Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Pediatric Orphan Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Pediatric Orphan Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Pediatric Orphan Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Recordati SpA Company Information, Head Office, and Major Competitors
    Table 6. Recordati SpA Major Business
    Table 7. Recordati SpA Pediatric Orphan Drugs Product and Solutions
    Table 8. Recordati SpA Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Recordati SpA Recent Developments and Future Plans
    Table 10. Novartis Company Information, Head Office, and Major Competitors
    Table 11. Novartis Major Business
    Table 12. Novartis Pediatric Orphan Drugs Product and Solutions
    Table 13. Novartis Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Novartis Recent Developments and Future Plans
    Table 15. Celgene Company Information, Head Office, and Major Competitors
    Table 16. Celgene Major Business
    Table 17. Celgene Pediatric Orphan Drugs Product and Solutions
    Table 18. Celgene Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Celgene Recent Developments and Future Plans
    Table 20. Abbvie Company Information, Head Office, and Major Competitors
    Table 21. Abbvie Major Business
    Table 22. Abbvie Pediatric Orphan Drugs Product and Solutions
    Table 23. Abbvie Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Abbvie Recent Developments and Future Plans
    Table 25. Orpharma Company Information, Head Office, and Major Competitors
    Table 26. Orpharma Major Business
    Table 27. Orpharma Pediatric Orphan Drugs Product and Solutions
    Table 28. Orpharma Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Orpharma Recent Developments and Future Plans
    Table 30. Amgen Company Information, Head Office, and Major Competitors
    Table 31. Amgen Major Business
    Table 32. Amgen Pediatric Orphan Drugs Product and Solutions
    Table 33. Amgen Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Amgen Recent Developments and Future Plans
    Table 35. Amryt Pharma Plc. Company Information, Head Office, and Major Competitors
    Table 36. Amryt Pharma Plc. Major Business
    Table 37. Amryt Pharma Plc. Pediatric Orphan Drugs Product and Solutions
    Table 38. Amryt Pharma Plc. Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Amryt Pharma Plc. Recent Developments and Future Plans
    Table 40. Johnson & Johnson Company Information, Head Office, and Major Competitors
    Table 41. Johnson & Johnson Major Business
    Table 42. Johnson & Johnson Pediatric Orphan Drugs Product and Solutions
    Table 43. Johnson & Johnson Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Johnson & Johnson Recent Developments and Future Plans
    Table 45. GSK Company Information, Head Office, and Major Competitors
    Table 46. GSK Major Business
    Table 47. GSK Pediatric Orphan Drugs Product and Solutions
    Table 48. GSK Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. GSK Recent Developments and Future Plans
    Table 50. Bristol-Myers Squibb Company Company Information, Head Office, and Major Competitors
    Table 51. Bristol-Myers Squibb Company Major Business
    Table 52. Bristol-Myers Squibb Company Pediatric Orphan Drugs Product and Solutions
    Table 53. Bristol-Myers Squibb Company Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Bristol-Myers Squibb Company Recent Developments and Future Plans
    Table 55. Roche Holding Company Information, Head Office, and Major Competitors
    Table 56. Roche Holding Major Business
    Table 57. Roche Holding Pediatric Orphan Drugs Product and Solutions
    Table 58. Roche Holding Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Roche Holding Recent Developments and Future Plans
    Table 60. Pfizer Company Information, Head Office, and Major Competitors
    Table 61. Pfizer Major Business
    Table 62. Pfizer Pediatric Orphan Drugs Product and Solutions
    Table 63. Pfizer Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Pfizer Recent Developments and Future Plans
    Table 65. Sanofi Company Information, Head Office, and Major Competitors
    Table 66. Sanofi Major Business
    Table 67. Sanofi Pediatric Orphan Drugs Product and Solutions
    Table 68. Sanofi Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Sanofi Recent Developments and Future Plans
    Table 70. Takeda Company Information, Head Office, and Major Competitors
    Table 71. Takeda Major Business
    Table 72. Takeda Pediatric Orphan Drugs Product and Solutions
    Table 73. Takeda Pediatric Orphan Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Takeda Recent Developments and Future Plans
    Table 75. Global Pediatric Orphan Drugs Revenue (USD Million) by Players (2018-2023)
    Table 76. Global Pediatric Orphan Drugs Revenue Share by Players (2018-2023)
    Table 77. Breakdown of Pediatric Orphan Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in Pediatric Orphan Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 79. Head Office of Key Pediatric Orphan Drugs Players
    Table 80. Pediatric Orphan Drugs Market: Company Product Type Footprint
    Table 81. Pediatric Orphan Drugs Market: Company Product Application Footprint
    Table 82. Pediatric Orphan Drugs New Market Entrants and Barriers to Market Entry
    Table 83. Pediatric Orphan Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global Pediatric Orphan Drugs Consumption Value (USD Million) by Type (2018-2023)
    Table 85. Global Pediatric Orphan Drugs Consumption Value Share by Type (2018-2023)
    Table 86. Global Pediatric Orphan Drugs Consumption Value Forecast by Type (2024-2029)
    Table 87. Global Pediatric Orphan Drugs Consumption Value by Application (2018-2023)
    Table 88. Global Pediatric Orphan Drugs Consumption Value Forecast by Application (2024-2029)
    Table 89. North America Pediatric Orphan Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 90. North America Pediatric Orphan Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 91. North America Pediatric Orphan Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 92. North America Pediatric Orphan Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 93. North America Pediatric Orphan Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 94. North America Pediatric Orphan Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 95. Europe Pediatric Orphan Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 96. Europe Pediatric Orphan Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 97. Europe Pediatric Orphan Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 98. Europe Pediatric Orphan Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 99. Europe Pediatric Orphan Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Pediatric Orphan Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Pediatric Orphan Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 102. Asia-Pacific Pediatric Orphan Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 103. Asia-Pacific Pediatric Orphan Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 104. Asia-Pacific Pediatric Orphan Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 105. Asia-Pacific Pediatric Orphan Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 106. Asia-Pacific Pediatric Orphan Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 107. South America Pediatric Orphan Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 108. South America Pediatric Orphan Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 109. South America Pediatric Orphan Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 110. South America Pediatric Orphan Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 111. South America Pediatric Orphan Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 112. South America Pediatric Orphan Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 113. Middle East & Africa Pediatric Orphan Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 114. Middle East & Africa Pediatric Orphan Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 115. Middle East & Africa Pediatric Orphan Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 116. Middle East & Africa Pediatric Orphan Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Pediatric Orphan Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 118. Middle East & Africa Pediatric Orphan Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 119. Pediatric Orphan Drugs Raw Material
    Table 120. Key Suppliers of Pediatric Orphan Drugs Raw Materials
List of Figures
    Figure 1. Pediatric Orphan Drugs Picture
    Figure 2. Global Pediatric Orphan Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Pediatric Orphan Drugs Consumption Value Market Share by Type in 2022
    Figure 4. Oncology Drugs
    Figure 5. Gastrointestinal Drugs
    Figure 6. Neurology Drugs
    Figure 7. Cardio-vascular Drugs
    Figure 8. Others
    Figure 9. Global Pediatric Orphan Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Pediatric Orphan Drugs Consumption Value Market Share by Application in 2022
    Figure 11. Hospital Pharmacies Picture
    Figure 12. Retail pharmacies Picture
    Figure 13. Others Picture
    Figure 14. Global Pediatric Orphan Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Pediatric Orphan Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Pediatric Orphan Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Pediatric Orphan Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Pediatric Orphan Drugs Consumption Value Market Share by Region in 2022
    Figure 19. North America Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Pediatric Orphan Drugs Revenue Share by Players in 2022
    Figure 25. Pediatric Orphan Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Pediatric Orphan Drugs Market Share in 2022
    Figure 27. Global Top 6 Players Pediatric Orphan Drugs Market Share in 2022
    Figure 28. Global Pediatric Orphan Drugs Consumption Value Share by Type (2018-2023)
    Figure 29. Global Pediatric Orphan Drugs Market Share Forecast by Type (2024-2029)
    Figure 30. Global Pediatric Orphan Drugs Consumption Value Share by Application (2018-2023)
    Figure 31. Global Pediatric Orphan Drugs Market Share Forecast by Application (2024-2029)
    Figure 32. North America Pediatric Orphan Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Pediatric Orphan Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America Pediatric Orphan Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Pediatric Orphan Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Pediatric Orphan Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe Pediatric Orphan Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Pediatric Orphan Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Pediatric Orphan Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific Pediatric Orphan Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Pediatric Orphan Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Pediatric Orphan Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America Pediatric Orphan Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Pediatric Orphan Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Pediatric Orphan Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa Pediatric Orphan Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Pediatric Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 66. Pediatric Orphan Drugs Market Drivers
    Figure 67. Pediatric Orphan Drugs Market Restraints
    Figure 68. Pediatric Orphan Drugs Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Pediatric Orphan Drugs in 2022
    Figure 71. Manufacturing Process Analysis of Pediatric Orphan Drugs
    Figure 72. Pediatric Orphan Drugs Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Companies Mentioned

Recordati SpA
Novartis
Celgene
Abbvie
Orpharma
Amgen
Amryt Pharma Plc.
Johnson & Johnson
GSK
Bristol-Myers Squibb Company
Roche Holding
Pfizer
Sanofi
Takeda